NCT00326274

Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: —
• Sponsor: Loreal USA · Industry
• Sex: All
• Age: 6 Months – 12 Years
• Healthy volunteers: —

Summary

The purpose of this study is to determine the safety potential of Helioblock® SX Cream as a sunscreen product in long term intermittent use conditions among pediatric subjects.. Each subject will be enrolled to participate for six months. The test product should be applied every day that outdoor activities are planned, prior to any significant sun exposure during out-door activities (such as the beach, outdoor sport activities), or whenever the subject needs to be protected against sunburn or other damage due to the sun. A minimum of 14 days test product use and sun exposure is required.

Conditions

• Sunburn

Interventions

Type	Name	Description
DRUG	Helioblock® SX Cream

Timeline

• Start date: 2006-05-01
• Primary completion: 2006-11-01
• Completion: 2006-11-01
• First posted: 2006-05-16
• Last updated: 2009-02-11

Locations

1 site across 1 country: United States